HIGHLIGHTS
- who: Mingyuan Pan from the Fudan University, Shanghai, China have published the research: Dosimetric quality of HyperArc in boost radiotherapy for single glioblastoma: comparison with CyberKnife and manual VMAT, in the Journal: (JOURNAL)
- what: The authors compared the dosimetric quality of HyperArc with the well-established CyberKnife (CK) and conventional VMAT methods of SRT for a single large target. The authors aimed to evaluate the dosimetric quality of HyperArc in comparison with other techniques for providing boost therapy for solitary GBM lesions with large volumes. The authors compared the mean dose of each OAR instead . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.